Compare ZVRA & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZVRA | PML |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.4M | 502.0M |
| IPO Year | 2015 | N/A |
| Metric | ZVRA | PML |
|---|---|---|
| Price | $8.35 | $7.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.71 | N/A |
| AVG Volume (30 Days) | ★ 912.1K | 188.0K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.65% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $84,388,000.00 | N/A |
| Revenue This Year | $333.25 | N/A |
| Revenue Next Year | $43.70 | N/A |
| P/E Ratio | $15.52 | ★ N/A |
| Revenue Growth | ★ 244.60 | N/A |
| 52 Week Low | $6.19 | $6.92 |
| 52 Week High | $13.16 | $9.46 |
| Indicator | ZVRA | PML |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 47.87 |
| Support Level | $8.21 | $7.45 |
| Resistance Level | $9.02 | $7.64 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 32.18 | 71.05 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.